Controlling the Poly(ε‐caprolactone) Degradation to Maintain the Stemness and Function of Adipose‐Derived Mesenchymal Stem Cells in Vascular Regeneration Application
- 22 October 2020
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 21 (1) , e2000226
Abstract
Biodegradable poly(ε‐caprolactone) (PCL) scaffolds with adipose‐derived mesenchymal stem cells (ADSCs) have been used in vascular regeneration studies. An evaluation method of the effect of PCL degradation products (DP) on the viability, stemness, and differentiation capacities of ADSCs is established. ADSCs are cultured in medium containing different concentrations of PCL DP before evaluating the effect of PCL DP on the cell apoptosis and proliferation, cell surface antigens, adipogenic and osteogenic differentiation capacities, and capacities to differentiate into endothelial cells and smooth muscle cells. The results demonstrate that PCL DP exceed 0.05 mg mL−1 may change the stemness and differentiation capacities of ADSCs. Therefore, to control the proper concentration of PCL DP is essential for ADSCs in vascular regeneration application.Keywords
This publication has 53 references indexed in Scilit:
- Therapeutic strategies to combat neointimal hyperplasia in vascular graftsExpert Review of Cardiovascular Therapy, 2012
- Growth and endothelial differentiation of adipose stem cells on polycaprolactoneJournal of Biomedical Materials Research Part A, 2011
- Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic PotentialBone Marrow Research, 2010
- Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serum-free cultureBiochemical and Biophysical Research Communications, 2010
- Adipose-Derived Stem Cells for Regenerative MedicineCirculation Research, 2007
- Concise Review: Adipose Tissue-Derived Stromal Cells—Basic and Clinical Implications for Novel Cell-Based TherapiesStem Cells, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Hydrogen Ion-Dependent Oncogenesis and Parallel New Avenues to Cancer Prevention and Treatment Using a H+-Mediated Unifying Approach: pH-Related and pH-Unrelated MechanismsCritical Reviews™ in Oncogenesis, 1995
- Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.Journal of Cell Biology, 1991
- Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes.Journal of Histochemistry & Cytochemistry, 1989